esorubicin has been researched along with Stomach Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akman, S; Blayney, D; Doroshow, J; Leong, L; Margolin, K; McNamara, M; Morgan, R; Multhauf, P; Raschko, J; Somlo, G | 1 |
1 trial(s) available for esorubicin and Stomach Neoplasms
| Article | Year |
|---|---|
Phase II study of 4'-deoxydoxorubicin (esorubicin) in advanced or metastatic adenocarcinoma of the stomach.
Topics: Adenocarcinoma; Adult; Aged; Doxorubicin; Drug Evaluation; Female; Humans; Male; Middle Aged; Stomach Neoplasms | 1991 |